01 Oct Doctor Máximo Zimerman assumed as the new Medical Director of Alcla
In September, Dr. Máximo Zimerman-doctor specialist in Neurology and Neuro rehabilitation-assumed the Medical Direction of Alcla. With his incorporation, the institution plans to continue with its sustained growth in the field of neurological rehabilitation. During the past year, the percentage of patients treated with neurological sequelae reached 55% of the total.
Dr. Zimerman explains: “There are many people who after a brain injury need treatment to recover their quality of life. In these cases, rehabilitation is a resource that must be applied immediately to resume the life that the patient had previously. Having an interdisciplinary team specialized in the recovery of patients and cutting edge technology, allow a successful reintegration of patients into social, family and work life”.
Máximo Zimerman graduated as a doctor from the medical school of the University of Tucumán (UNT), and received his Doctorate in Neurosciences from the University Hospital of Hamburg (Germany). Between 2001 and 2006, he completed his residency in Neurology at the Hospital Francés in Buenos Aires. He then received the DAAD Scholarship (German Office for Academic Exchange) to carry out his Doctorate in the Brain Imaging and Neurostimulation Laboratory (BINS) dependent on the Department of Neurology of the University Hospital of Hamburg. Throughout this period, he developed different projects related to brain neuroplastic mechanisms that occur after injuries to the central nervous system. Based on them, he works on new therapeutic strategies for the recovery of motor function and language in patients with stroke.
Dr. Zimerman has presented the results of his research at prestigious international conferences. In 2013, he received his PhD in Neurosciences from the University Hospital of Hamburg with the highest qualification.
He revalidated his medical degree in Germany, developing his care activity in the Department of Neurology of the University Hospital of Hamburg. His responsibility consisted in the treatment of patients with neurological damage, coordinating the spasticity clinic of the department of said hospital until 2016. At the same time, he began his post-doctorate in neuroplasticity and neuro rehabilitation.
Dr. Zimerman will be accompanied in his new role in Alcla by Dr. Jorge San Juan as Deputy Director, aspecialist in Infectious Diseases and Infection Control with great prestige and experience.
The assumption of Dr. Zimerman, added to the recent accreditation of the CARF International Quality Standard, encourages Alcla continue on working for the constant improvement of the service, while promoting at the same time its growth at the national and international levels.